Fang Qian

Title: The Innovations of Fang Qian

Introduction

Fang Qian is an accomplished inventor based in Southborough, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-transferrin receptor antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Fang Qian holds a patent for "Anti-transferrin receptor antibodies and uses thereof." This patent provides a comprehensive disclosure of anti-transferrin receptor antibodies, including compositions that comprise these antibodies and methods for their use. The patent also details polynucleotides and vectors encoding the antibodies, as well as methods for producing these antibodies and the cells that contain them.

Career Highlights

Fang Qian is currently employed at Biogen MA Inc., a leading biotechnology company known for its focus on developing therapies for neurological diseases. His role at Biogen has allowed him to further his research and contribute to groundbreaking advancements in the field.

Collaborations

Fang collaborates with talented professionals, including Isin Dalkilic-Liddle and Benjamin A. Smith. These collaborations enhance the innovative environment at Biogen and contribute to the success of their projects.

Conclusion

Fang Qian's work exemplifies the spirit of innovation in biotechnology. His patent on anti-transferrin receptor antibodies highlights the potential for new therapeutic approaches in medicine. Through his career at Biogen, he continues to make valuable contributions to the field.